ABSTRACT
Two major neurotrophic factors, nerve growth factor (NGF) and brain-derived neurotrophic factor (BDNF) are involved in a number of physiological processes associated with neuronal growth, survival and plasticity. There are an increasing number of papers demonstrating their ability to serve as neuroprotective molecules under various pathological conditions. At the same time, it remains unclear whether both NGF and BDNF have similar roles under pathological conditions and their effects on the electrophysiological properties of neurons after acute pathogen exposure. In the present paper we investigated the neuroprotective role of these two neurotrophins in a well-characterized model of beta-amyloid peptide (Aß)-dependent impairment of long-term potentiation (LTP). Using lentiviral gene delivery we performed long-term elevation of neurotrophin expression in the dentate gyrus (DG) of rats. One week after virus injection acute brain slices were incubated with beta-amyloid (25-35) for 1h and afterward in vitro LTP induction was performed in medial perforant path-DG synapses. We demonstrate that chronic elevation of NGF but not BDNF concentration protects LTP induction from beta-amyloid action. Further inhibitory analysis suggests that the effect of NGF is mediated by PI3K-signaling cascade.
Subject(s)
Amyloid beta-Peptides/toxicity , Brain-Derived Neurotrophic Factor/metabolism , Dentate Gyrus/physiopathology , Long-Term Potentiation/physiology , Nerve Growth Factor/metabolism , Peptide Fragments/toxicity , Amyloid beta-Peptides/metabolism , Animals , Brain-Derived Neurotrophic Factor/genetics , Chromones/pharmacology , Dentate Gyrus/drug effects , Enzyme Inhibitors/pharmacology , Gene Transfer Techniques , Genetic Vectors , HEK293 Cells , Humans , Lentivirus/genetics , Male , Morpholines/pharmacology , Nerve Growth Factor/genetics , Peptide Fragments/metabolism , Perforant Pathway/drug effects , Perforant Pathway/physiopathology , Phosphatidylinositol 3-Kinases/metabolism , Phosphoinositide-3 Kinase Inhibitors , Random Allocation , Rats, Wistar , Tissue Culture TechniquesABSTRACT
In the present work, the forward and/or reversed Na+/Ca2+ exchange in cerebellar granular cells was suppressed by substitution of Na+o by Li+ before, during, and after exposure to glutamate for varied time and also using the inhibitor KB-R7943 of the reversed exchange. After glutamate challenge for 1 min, Na+o/Li+ substitution did not influence the recovery of low [Ca2+]i in a calcium-free medium. A 1-h incubation with 100 microM glutamate induced in the neurons a biphasic and irreversible [Ca2+]i rise (delayed calcium deregulation (DCD)), enhancement of [Na+]i, and decrease in the mitochondrial potential. If Na+o had been substituted by Li+ before the application of glutamate, i.e. the exchange reversal was suppressed during the exposure to glutamate, the number of cells with DCD was nearly fourfold lowered. However, addition of the Na+/K+-ATPase inhibitor ouabain (0.5 mM) not preventing the exchange reversal also decreased DCD in the presence of glutamate. Both exposures decreased the glutamate-caused loss of intracellular ATP. Glucose deprivation partially abolished protective effects of the Na+o/Li+ substitution and ouabain. KB-R7943 (10 microM) increased 7.4-fold the number of cells with the [Ca2+]i decreased to the basal level after the exposure to glutamate. Thus, reversal of the Na+/Ca2+ exchange reinforced the glutamate-caused perturbations of calcium homeostasis in the neurons and slowed the recovery of the decreased [Ca2+]i in the post-glutamate period. However, for development of DCD, in addition to the exchange reversal, other factors are required, in particular a decrease in the intracellular concentration of ATP.
Subject(s)
Calcium/metabolism , Glutamates/metabolism , Neurons/metabolism , Sodium-Potassium-Exchanging ATPase/metabolism , Sodium/metabolism , Adenosine Triphosphate/metabolism , Animals , Calcium/pharmacology , Cells, Cultured , Cerebellum/cytology , Cytoplasm/metabolism , Glucose/metabolism , Lithium Compounds/pharmacology , Membrane Potential, Mitochondrial , Neurons/drug effects , Ouabain/pharmacology , Rats , Rats, Wistar , Sodium-Potassium-Exchanging ATPase/antagonists & inhibitors , Thiourea/analogs & derivatives , Thiourea/pharmacologyABSTRACT
Semax (100 microM) and its Pro-Gly-Pro fragment (20 and 100 microM) delayed the development of calcium dysregulation and reduction of the mitochondrial potential in cultured cerebellar granule cells under conditions of glutamate neurotoxicity. Incubation with these peptides improved neuronal survival by on average 30%. The neuroprotective effect of semax in cerebral ischemia/hypoxia can be due to improvement of mitochondrial resistance to "calcium" stress.
